Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Adaptive Randomised Placebo Controlled Phase II Trial of Antivirals for COVID-19 Infection

NCT04445467 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.

NCT NCT04445467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04445467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Adaptive Randomised Placebo Controlled Phase II Trial of Antivirals for COVID-19 Infection
Lead sponsor
Bayside Health
Phase
Phase 2
Overall status
Unknown status
Start date
July 30, 2020
Completion date
December 31, 2021
Enrollment
190 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid